EHRA Premium Access

Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes in patients with atrial fibrillation and type 2 diabetes mellitus

Congress Presentation

About the speaker

Doctor Young Choi

Seoul St. Mary's Hospital, Seoul (Korea (Republic of))
0 follower

8 more presentations in this session

Associations of general and abdominal obesity, and genetic risk with atrial fibrillation: longitudinal analyses in the UK biobank study

Speaker: Doctor S. Choi (Seoul, KR)


Patterns of pulmonary vein activity that may help identify patients who need further ablation beyond pulmonary vein isolation in persistent AF

Speaker: Doctor Y. Prudat (Lausanne, CH) Doctor P. Pascale (Lausanne, CH)


Volumetric quantification of peri-atrial fat inflammation in atrial fibrillation patients

Speaker: Doctor K. Vickneson (Edinburgh, GB)


Myeloperoxidase causes both arrhythmogenic structural and electrical remodelling in neonatal rat ventricular myocyte monolayers

Speaker: Mrs R. Al-Shama (Amsterdam, NL)


Outcomes associated with sodium glucose co-transporter 2 inhibitors in anticoagulated atrial fibrillation patients

Speaker: Doctor A. Fawzy (Liverpool, GB)


Access the full session

Atrial Fibrillation - Round 6 - Mechanisms - Pathophysiology

Speakers: Doctor Y. Choi, Doctor S. Choi, Doctor Y. Prudat, Doctor P. Pascale, Doctor K. Vickneson...

About the event


EHRA 2023

16 April - 18 April 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb